CAG repeat number governs the development rate of pathology in Huntington's disease
- 1 May 1997
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 41 (5) , 689-692
- https://doi.org/10.1002/ana.410410521
Abstract
We compared the number of CAG repeats, the age at death, and the severity of neuropathology in 89 Huntington's disease brains. We found a linear correlation between the CAG repeat number and the quotient of the degree of atrophy in the striatum (the brain region most severely affected in Huntington's disease) divided by age at death, with an intercept at 35.5 repeats. The largest CAG repeat length, therefore, at which no pathology is expected to develop is 35.5. These results imply that striatal damage in Huntington's disease is almost entirely a lineaar function of the length of the polyglutamine stretch beyond 35.5 glutamines multiplied by the age of the patient. Thus, it is predicted that the pathological process develops linearly from birth. Analysis of other measures of striatal function could test this hypothesis and might determine when treatment for CAG repeat diseases should start.Keywords
This publication has 21 references indexed in Scilit:
- Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tractNature Genetics, 1996
- Relationship between trinucliotide repeats and neuropathological changes in Huntington's dieaseAnnals of Neurology, 1996
- A huntingtin-associated protein enriched in brain with implications for pathologyNature, 1995
- Huntington's disease: CAG genetics expands neurobiologyCurrent Opinion in Neurobiology, 1995
- Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brainsNeurobiology of Disease, 1994
- Trinucleotide repeat length and progression of illness in Huntington's disease.Journal of Medical Genetics, 1994
- Trinucleotide repeat length and rate of progression of Huntington's diseaseAnnals of Neurology, 1994
- A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomesMolecular and Cellular Probes, 1993
- Evidence of presymptomatic cognitive decline in Huntington's diseaseJournal of Clinical and Experimental Neuropsychology, 1992
- A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's diseaseAnnals of Neurology, 1990